Cernostics CEO on the opportunities ahead with Castle's acquisition

The Pittsburgh-based company's lead product is Tissue Cypher, which uses artificial intelligence and spatial biology to help physicians determine who of the patients diagnosed with a type of esophageal damage, Barrett's Esophagus, will go on to develop esophageal cancer.

Source: bizjournals.com Health Care News Headlines - October 22, 2021 Category: Health Management Authors: Paul J. Gough Source Type: news